The Comparative Genomic Hybridization (CGH) Software market refers to the industry that provides software solutions for analyzing genomic data. As the demand for genetic analysis and diagnostics continues to rise, the Comparative Genomic Hybridization (CGH) Software market size is expected to witness significant growth, driven by its increasing applications in research, diagnostics, and personalized medicine. The growth outlook for the CGH Software market appears promising, with a projected market forecast of $1.4 billion by 2026, growing at a CAGR of 12.1% from 2021 to 2033. This industry expansion is primarily driven by technological advancements, increasing adoption of genetic testing, and the rising incidence of genetic disorders. The scope of the CGH Software market encompasses various synonyms such as array-based CGH, molecular cytogenetics, and genomic microarray analysis.